Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis

BMC Musculoskeletal Disorders

Volumn 12, Issue , 2011, Pages

  Kauther, Max D ^a   Bachmann, Hagen S ^a   Neuerburg, Laura ^a   Broecker Preuss, Martina ^a   Hilken, Gero ^a   Grabellus, Florian ^a   Koehler, Gabriele ^b   Von Knoch, Marius ^a,c   Wedemeyer, Christian ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Klinikum Bremerhaven Reinkenheide   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN; OSTEOPROTEGERIN; ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE; BONE DENSITY CONSERVATION AGENT; MICROSPHERE; POLYETHYLENE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; HORMONE SUBSTITUTION; IMPLANTATION; IN VIVO STUDY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTEIN BLOOD LEVEL; URINALYSIS; ANIMAL; BLOOD; C57BL MOUSE; CELL COUNT; DISEASE MODEL; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; PROSTHESIS FAILURE; SKULL; TREATMENT OUTCOME;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; CALCITONIN; CELL COUNT; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSPHERES; OSTEOCLASTS; OSTEOLYSIS; OSTEOPROTEGERIN; POLYETHYLENE; PROSTHESIS FAILURE; SKULL; TREATMENT OUTCOME;

EID: 80051598290     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-12-186     Document Type: Article

References (40)

1. What's new in orthopaedic research. Silva MJ, Sandell LJ, J Bone Joint Surg Am 2002 84-A 1490 1496 12177292 (Pubitemid 35407603)
2. Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Willert HG, Bertram H, Buchhorn GH, Clin Orthop Relat Res 1990 258 95 107 2203577
3. High levels of substance P and CGRP in pseudosynovial fluid from patients with aseptic loosening of their hip prosthesis. Qian Y, Zeng BF, Zhang XL, Jiang Y, Acta Orthop 2008 79 342 345 10.1080/17453670710015238 18622837 (Pubitemid 352009329)
4. Sensory nerves in the interface membrane of aseptic loose hip prostheses. Ahmed M, Bergstrom J, Lundblad H, Gillespie WJ, Kreicbergs A, J Bone Joint Surg Br 1998 80 151 155 10.1302/0301-620X.80B1.8138 9460973 (Pubitemid 28048509)
5. Polyethylene particle-induced bone resorption in alpha-calcitonin gene-related peptide-deficient mice. Wedemeyer C, Neuerburg C, Pfeiffer A, Heckelei A, Bylski D, von Knoch F, Schinke T, Hilken G, Gosheger G, von Knoch M, Loer F, Saxler G, J Bone Miner Res 2007 22 1011 1019 10.1359/jbmr.070408 17419680 (Pubitemid 351339723)
6. Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. Gangula PRR, Zhao HW, Supowit SC, Wimalawansa SJ, Dipette DJ, Westlund KN, Gagel RF, Yallampalli C, Hypertension 2000 35 470 475 10642343 (Pubitemid 30054218)
7. Elevated sympathetic nervous activity in mice deficient in alpha CGRP. Oh-hashi Y, Shindo T, Kurihara Y, Imai T, Wang YH, Morita H, Imai Y, Kayaba Y, Nishimatsu H, Suematsu Y, Hirata Y, Yazaki Y, Nagai R, Kuwaki T, Kurihara H, Circulation Research 2001 89 983 990 10.1161/hh2301.100812 11717154 (Pubitemid 34640864)
8. Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders? Akopian A, Demulder A, Ouriaghli F, Corazza F, Fondu P, Bergmann P, Peptides 2000 21 559 564 10.1016/S0196-9781(00)00185-6 10822112 (Pubitemid 30261574)
9. Calcitonin gene-related peptide inhibits osteoclastic bone resorption: a comparative study. Zaidi M, Fuller K, Bevis PJ, GainesDas RE, Chambers TJ, MacIntyre I, Calcif Tissue Int 1987 40 149 154 10.1007/BF02555699 3105845 (Pubitemid 17015905)
10. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM, Nature 1982 298 240 244 10.1038/298240a0 6283379 (Pubitemid 12089405)
11. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone. Lerner UH, J Musculoskelet Neuronal Interact 2006 6 87 95 16675892 (Pubitemid 43732831)
12. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes. Gooi JH, Pompolo S, Karsdal MA, Kulkarni NH, Kalajzic I, Mc Ahren SH, Han B, Onyia JE, Ho PW, Gillespie MT, Walsh NC, Chia LY, Quinn JM, Martin TJ, Sims NA, Bone 2010 46 1486 1497 10.1016/j.bone.2010.02.018 20188226
13. Calcitonin-Physiology and Patho-Physiology. Austin LA, Heath H, New England Journal of Medicine 1981 304 269 278 10.1056/NEJM198101293040505 7003392
14. Calcitonin Alters Behavior of Isolated Osteoclasts. Chambers TJ, Magnus CJ, Journal of Pathology 1982 136 27 39 10.1002/path.1711360104 7057295 (Pubitemid 12213616)
15. Calcitonin for Prevention and Treatment of Osteoporosis. Reginster JY, American Journal of Medicine 1993 95 44 S47 10.1016/0002-9343(93)90382-Y
16. Paget disease of bone. Roodman GD, Windle JJ, Journal of Clinical Investigation 2005 115 200 208 15690073 (Pubitemid 40385458)
17. A Double-Blind, Placebo-Controlled, Dose-Finding Trial of Intermittent Nasal Salmon-Calcitonin for Prevention of Postmenopausal Lumbar Spine Bone Loss. Reginster JY, Deroisy R, Lecart MP, Sarlet N, Zegels B, Jupsin I, Delongueville M, Franchimont P, American Journal of Medicine 1995 98 452 458 10.1016/S0002-9343(99)80344-1 7733123
18. Oral calcitonin inhibits bone resorption: A pilot dose-finding study. Cosma M, Buclin T, Burckhardt P, Azria M, Attinger M, McLeod J, Journal of Bone and Mineral Research 2001 16 180 S180
19. Human Synthetic Calcitonin Gene-Related Peptide Inhibits Bone-Resorption Invitro. Dsouza SM, Macintyre I, Girgis SI, Mundy GR, Endocrinology 1986 119 58 61 10.1210/endo-119-1-58 3487444 (Pubitemid 16100707)
20. Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. Hoff AO, Catala-Lehnen P, Thomas PM, Priemel M, Rueger JM, Nasonkin I, Bradley A, Hughes MR, Ordonez N, Cote GJ, Amling M, Gagel RF, J Clin Invest 2002 110 1849 1857 12488435 (Pubitemid 36076492)
21. Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues. Kapurniotu A, Taylor JW, J Med Chem 1995 38 836 847 10.1021/jm00005a011 7877149
22. [Size and shape of commercially available polyethylene particles for in-vitro and in-vivo-experiments]. von Knoch M, Sprecher C, Barden B, Saxler G, Loer F, Wimmer M, Z Orthop Ihre Grenzgeb 2004 142 366 370 10.1055/s-2004-822589 15250012 (Pubitemid 38887890)
23. Polyethylene particle-induced bone resorption in substance P-deficient mice. Wedemeyer C, Neuerburg C, Pfeiffer A, Heckelei A, von Knoch F, Hilken G, Brankamp J, Henschke F, von Knoch M, Loer F, Saxler G, Calcif Tissue Int 2007 80 268 274 10.1007/s00223-007-9005-5 17401694 (Pubitemid 46675248)
24. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. Schwarz EM, Lu AP, Goater JJ, Benz EB, Kollias G, Rosier RN, Puzas JE, O'Keefe RJ, J Orthop Res 2000 18 472 480 10.1002/jor.1100180321 10937636 (Pubitemid 30599625)
25. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, J Bone Miner Res 1987 2 595 610 3455637
26. The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles. Atkins GJ, Welldon KJ, Holding CA, Haynes DR, Howie DW, Findlay DM, Biomaterials 2009 30 3672 3681 10.1016/j.biomaterials. 2009.03.035 19349075
27. Localization of SP- and CGRP-immunopositive nerve fibers in the hip joint of patients with painful osteoarthritis and of patients with painless failed total hip arthroplasties. Saxler G, Loer F, Skumavc M, Pfortner J, Hanesch U, European Journal of Pain 2007 11 67 74 16460974 (Pubitemid 44636277)
28. Calcitonin deficiency in mice progressively results in high bone turnover. Huebner AK, Schinke T, Priemel M, Schilling S, Schilling AF, Emeson RB, Rueger JM, Amling M, J Bone Miner Res 2006 21 1924 1934 10.1359/jbmr.060820 17002587 (Pubitemid 44851569)
29. The role of calcitonin and alpha-calcitonin gene-related peptide in bone formation. Huebner AK, Keller J, Catala-Lehnen P, Perkovic S, Streichert T, Emeson RB, Amling M, Schinke T, Arch Biochem Biophys 2008 473 210 217 10.1016/j.abb.2008.02.013 18307972
30. Biochemical markers of particle induced osteolysis in C57BL/6 mice. Kauther MD, Zimmermann C, Bachmann H, Broecker-Preuss M, Hilken G, von Knoch M, Wedemeyer C, Clin Chem Lab Med 2010 13
31. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. Naot D, Cornish J, Bone 2008 43 813 818 10.1016/j.bone.2008.07.003 18687416
32. Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR, Bone 2001 29 162 168 10.1016/S8756-3282(01)00494-X 11502478 (Pubitemid 32737190)
33. Calcitonin promotes osteoclast survival in vitro. Selander KS, Harkonen PL, Valve E, Monkkonen J, Hannuniemi R, Vaananen HK, Molecular and Cellular Endocrinology 1996 122 119 129 10.1016/0303-7207(96)03870-1 8902842 (Pubitemid 126351942)
34. Calcitonin Directly Acts on Mouse Osteoblastic Mc3t3-E1 Cells to Stimulate Messenger-Rna Expression of C-Fos, Insulin-Like Growth-Factor-I and Osteoblastic Phenotypes (Type-1 Collagen and Osteocalcin). Kobayashi T, Sugimoto T, Saijoh K, Fukase M, Chihara K, Biochemical and Biophysical Research Communications 1994 199 876 880 10.1006/bbrc.1994.1310 8135834 (Pubitemid 24181743)
35. Characterization of an Osteoblast-Like Clonal Cell-Line Which Responds to Both Parathyroid-Hormone and Calcitonin. Forrest SM, Ng KW, Findlay DM, Michelangeli VP, Livesey SA, Partridge NC, Zajac JD, Martin TJ, Calcified Tissue International 1985 37 51 56 10.1007/BF02557679 3922597 (Pubitemid 15102237)
36. New factors controlling bone remodeling. Marie P, Debiais F, Cohen-Solal M, de Vernejoul MC, Joint Bone Spine 2000 67 150 156 10875310 (Pubitemid 30353449)
37. Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, Gebre-Medhin S, Galson DL, Zajac JD, Karsenty G, J Cell Biol 2004 164 509 514 10.1083/jcb.200312135 14970190 (Pubitemid 38233312)
38. Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. Davey RA, Turner AG, McManus JF, Chiu WS, Tjahyono F, Moore AJ, Atkins GJ, Anderson PH, Ma C, Glatt V, MacLean HE, Vincent C, Bouxein M, Morris HA, Findlay DM, Zajac JD, J Bone Miner Res 2008 23 1182 1193 10.1359/jbmr.080310 18627265 (Pubitemid 352040174)
39. Radiographic and micro-computed tomographic imaging of lipopolysaccaride-mediated bone resorption. Lee DH, Jung Jy, Chole RA, Ann Otol Rhinol Laryngol 2009 118 391 396 19548390
40. Bcl2-938c > a and Calca-1786t < C Polymorphisms in Aseptic Loosened Total Hip Arthroplasty. Wedemeyer C, Kauther MD, Hanenkamp S, Nuckel H, Bau M, Siffert W, Bachmann HS, European Journal of Medical Research 2009 14 250 255 19541585